EUVIMEDEUVIMED entdecken
Multizentrische Studie

Antibodies Are Predictive for Diagnosis of Celiac Disease in Pediatric Type 1 Diabetes

Nadja Zoe Müller, Iulia-Maia Muresan, Arnaud Künzi, Zamir-Zoran Borojevic, Barblin Remund, Marie-Anne Burckhardt iD, Claudia Boettcher, Christiane Sokollik iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf146 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Nadja Zoe Müller und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern…. Hauptthemen laut MEDLINE: Celiac Disease, Diabetes Mellitus, Type 1, Autoantibodies, Immunoglobulin A. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Children and adolescents with type 1 diabetes (T1D) have a higher risk of developing celiac disease (CD) than the general population. However, the main screening antibody, IgA anti-transglutaminase 2 (TGA-IgA), can fluctuate in T1D and there is no threshold for performing diagnostic biopsies.

Objectives

The study aims to define an optimal TGA-IgA cutoff for performing diagnostic biopsies for CD confirmation and to assess whether tracking TGA-IgA evolution or adding other antibodies can improve biopsy indications.

Methods

Retrospective longitudinal analysis of pediatric T1D individuals diagnosed at 2 centers in Switzerland between 2000 and 2021, from T1D diagnosis to CD diagnosis or the age of 18 years.

Results

We included 588 individuals with T1D, comprising 2944 TGA-IgA values. Thirty-four (5.8%) developed CD during follow-up, of whom 50% had CD-associated symptoms at CD diagnosis. Balancing sensitivity and specificity TGA-IgA around 6.1 × upper limit of normal was the best cutoff for performing diagnostic biopsies. The inclusion of IgG antibodies against deamidated gliadin peptides achieved a higher area under the curve of 0.79 (95% CI, 0.6-1) with 80% accuracy compared to each antibody alone. CD diagnosis within 2 years of T1D, representing two thirds of CD, was marked by elevated TGA-IgA at T1D diagnosis. Later CD diagnosis was associated with a more gradual increase of TGA-IgA.

Conclusion

Our results suggest an indication for biopsy for CD confirmation at a TGA-IgA cutoff around 6.1 × upper limit of normal. Including IgG antibodies against deamidated gliadin peptides can potentially increase precision. TGA-IgA determination at T1D diagnosis may help to identify individuals at risk of CD early on.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseDiabetes Mellitus, Type 1AutoantibodiesImmunoglobulin AHumansChildMaleFemaleAdolescentRetrospective StudiesLongitudinal StudiesChild, PreschoolBiopsyTransglutaminasesProtein Glutamine gamma Glutamyltransferase 2BiomarkersGliadinPredictive Value of TestsSwitzerlandImmunoglobulin GGTP-Binding ProteinsFollow-Up StudiesInfantSensitivity and Specificity

Stichwörter der Autor:innen

IgA anti-transglutaminase 2 antibodyIgG anti-deamidated gliadin peptides antibodyscreening strategyserology

Substanzen

AutoantibodiesImmunoglobulin ATransglutaminasesProtein Glutamine gamma Glutamyltransferase 2BiomarkersGliadinImmunoglobulin GGTP-Binding Proteinsanti-transglutaminase autoantibody

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.
  • Department of Clinical Research, University of Bern, 3012 Bern, Switzerland.
  • Pediatric Endocrinology and Diabetology, University Children's Hospital Basel, 4031 Basel, Switzerland.
  • Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.

ORCID-Profile: Marie-Anne Burckhardt, Christiane Sokollik

Zitieren

APA

Müller, N. Z., Muresan, I. M., Künzi, A., Borojevic, Z. Z., Remund, B., Burckhardt, M. A., Boettcher, C., & Sokollik, C. (2025). Antibodies Are Predictive for Diagnosis of Celiac Disease in Pediatric Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf146

Vancouver

Müller NZ, Muresan IM, Künzi A, Borojevic ZZ, Remund B, Burckhardt MA, et al. Antibodies Are Predictive for Diagnosis of Celiac Disease in Pediatric Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf146

BibTeX
@article{Mller2025,
  author = {Müller, Nadja Zoe and Muresan, Iulia-Maia and Künzi, Arnaud and Borojevic, Zamir-Zoran and Remund, Barblin and Burckhardt, Marie-Anne and Boettcher, Claudia and Sokollik, Christiane},
  title = {Antibodies Are Predictive for Diagnosis of Celiac Disease in Pediatric Type 1 Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf146}
}
Kostenlos starten →